Development of a custom pentaplex sandwich immunoassay using Protein-G coupled beads for the Luminex® xMAP® platform

Journal of Immunological Methods

Volumn 433, Issue , 2016, Pages 6-16

  McDonald, Jacqueline U ^a   Ekeruche Makinde, Julia ^a   Ho, Mei M ^b   Tregoning, John S ^a   Ashiru, Omodele ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Beads; Biomarkers; Protein G; Sandwich immunoassay; Serum; XMAP

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; PROTEIN G; VACCINE; BACTERIAL PROTEIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN RECEPTOR; INFLUENZA VACCINE; MEMBRANE PROTEIN; MICROSPHERE; NERVE PROTEIN; NEURONAL PENTRAXIN; TREM1 PROTEIN, MOUSE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS REACTION; CUSTOM PENTAPLEX SANDWICH IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOASSAY; INFLAMMATION; MEASUREMENT; MEDICAL DEVICE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CHEMISTRY; IMMUNOLOGY; PROCEDURES;

ANIMALS; ANTIBODIES; BACTERIAL PROTEINS; BIOMARKERS; C-REACTIVE PROTEIN; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOASSAY; INFLUENZA VACCINES; MEMBRANE GLYCOPROTEINS; MICE; MICROSPHERES; NERVE TISSUE PROTEINS; RECEPTORS, IMMUNOLOGIC; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS-1;

EID: 84964763166     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2016.02.018     Document Type: Article

References (24)

1. Akerstrom B., Nielsen E., Bjorck L. Definition of IgG- and albumin-binding regions of streptococcal protein G. J. Biol. Chem. 1987, 262:13388-13391.
2. Bjorck L., Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J. Immunol. 1984, 133:969-974.
3. Bjorck L., Kastern W., Lindahl G., Wideback K. Streptococcal protein G, expressed by streptococci or by Escherichia coli, has separate binding sites for human albumin and IgG. Mol. Immunol. 1987, 24:1113-1122.
4. Caproni E., Tritto E., Cortese M., Muzzi A., Mosca F., Monaci E., Baudner B., Seubert A., De Gregorio E. MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action. J. Immunol. 2012, 188:3088-3098.
5. Christian L.M., Iams J.D., Porter K., Glaser R. Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine 2011, 29:8982-8987.
6. Ellington A.A., Kullo I.J., Bailey K.R., Klee G.G. Antibody-based protein multiplex platforms: technical and operational challenges. Clin. Chem. 2010, 56:186-193.
7. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
8. Houser B. Bio-Rad's Bio-Plex(R) suspension array system, xMAP technology overview. Arch. Physiol. Biochem. 2012, 118:192-196.
9. de Jager W., Rijkers G.T. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006, 38:294-303.
10. de Jager W., Prakken B.J., Bijlsma J.W., Kuis W., Rijkers G.T. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies. J. Immunol. Methods 2005, 300:124-135.
11. Kaufmann S.H., McElrath M.J., Lewis D.J., Del Giudice G. Challenges and responses in human vaccine development. Curr. Opin. Immunol. 2014, 28:18-26.
12. Khan I.H., Mendoza S., Yee J., Deane M., Venkateswaran K., Zhou S.S., Barry P.A., Lerche N.W., Luciw P.A. Simultaneous detection of antibodies to six nonhuman-primate viruses by multiplex microbead immunoassay. Clin. Vaccine Immunol. 2006, 13:45-52.
13. Lewczuk P. The pros and cons of multiplexing: a guest-editor's introduction. Methods 2012, 56:461-463.
14. Lewis D.J., Lythgoe M.P. Application of "Systems Vaccinology" to evaluate inflammation and reactogenicity of adjuvanted preventative vaccines. J. Immunol. Res. 2015, 2015:909406.
15. Mosca F., Tritto E., Muzzi A., Monaci E., Bagnoli F., Iavarone C., O'Hagan D., Rappuoli R., De Gregorio E. Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10501-10506.
16. Nakaya H.I., Wrammert J., Lee E.K., Racioppi L., Marie-Kunze S., Haining W.N., Means A.R., Kasturi S.P., Khan N., Li G.M., et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 2011, 12:786-795.
17. Nossal G.J. Vaccines and future global health needs. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2011, 366:2833-2840.
18. Obermoser G., Presnell S., Domico K., Xu H., Wang Y., Anguiano E., Thompson-Snipes L., Ranganathan R., Zeitner B., Bjork A., et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 2013, 38:831-844.
19. Rappuoli R., Pizza M., Del Giudice G., De Gregorio E. Vaccines, new opportunities for a new society. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:12288-12293.
20. Reis K.J., Boyle M.D., Ayoub E.M. Identification of distinct Fc-receptor molecules on streptococci and staphylococci. J. Clin. Lab. Immunol. 1984, 13:75-80.
21. Schwenk J.M., Lindberg J., Sundberg M., Uhlen M., Nilsson P. Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics. Mol. Cell. Proteomics 2007, 6:125-132.
22. Seubert A., Monaci E., Pizza M., O'Hagan D.T., Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J. Immunol. 2008, 180:5402-5412.
23. Staros J.V., Wright R.W., Swingle D.M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal. Biochem. 1986, 156:220-222.
24. Vignali D.A. Multiplexed particle-based flow cytometric assays. J. Immunol. Methods 2000, 243:243-255.